1. Home
  2. YDES vs IGR Comparison

YDES vs IGR Comparison

Compare YDES & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.20

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Logo CBRE Global Real Estate Income Fund of Beneficial Interest

IGR

CBRE Global Real Estate Income Fund of Beneficial Interest

HOLD

Current Price

$4.69

Market Cap

645.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDES
IGR
Founded
2013
2004
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
543.0M
645.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YDES
IGR
Price
$5.20
$4.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.7K
571.5K
Earning Date
04-30-2026
01-01-0001
Dividend Yield
N/A
13.93%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.00
$4.15
52 Week High
$25.00
$5.37

Technical Indicators

Market Signals
Indicator
YDES
IGR
Relative Strength Index (RSI) 35.34 52.73
Support Level N/A $4.65
Resistance Level $13.19 $4.89
Average True Range (ATR) 0.56 0.07
MACD 0.03 0.01
Stochastic Oscillator 13.42 37.50

Price Performance

Historical Comparison
YDES
IGR

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.

Share on Social Networks: